Page last updated: 2024-12-06

metaperiodate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Metaperiodate, also known as periodic acid, is a powerful oxidizing agent. It exists in various forms, including the anhydrous form (HIO4) and the monohydrate (HIO4·H2O). While it's not a common compound in everyday life, it plays a crucial role in various scientific and industrial applications.

**Synthesis:**

* Metaperiodate can be synthesized from sodium periodate (NaIO4) by acidification with strong acids like nitric acid.

**Effects:**

* **Oxidizing Agent:** Metaperiodate readily oxidizes various organic compounds, including alcohols, aldehydes, and ketones. This oxidation property makes it valuable in organic synthesis, particularly for selective oxidation reactions.
* **Analytical Chemistry:** It's used in analytical chemistry for determining the presence and concentration of certain substances, like carbohydrates and unsaturated compounds.
* **Biological Applications:** Some studies suggest its potential as an antimicrobial agent, although further research is necessary.

**Importance:**

* **Organic Synthesis:** Metaperiodate is an essential reagent in organic synthesis due to its ability to selectively oxidize specific functional groups, leading to the formation of valuable compounds.
* **Analytical Chemistry:** Its oxidizing properties are crucial for various analytical techniques used to identify and quantify organic compounds.
* **Potential Applications:** Ongoing research explores its potential applications in medicine, pharmaceuticals, and materials science.

**Why It's Studied:**

* **Oxidizing Properties:** Researchers are constantly investigating its oxidizing capabilities and exploring new applications in organic synthesis and analytical chemistry.
* **Potential Applications:** The potential of metaperiodate in various fields, including medicine and materials science, drives further research to unlock its full potential.

**Note:**

* While research into metaperiodate continues, its handling requires caution due to its oxidizing properties.
* Its applications and potential benefits are still being investigated, and further research is needed to understand its full scope and safety aspects.'

metaperiodate: RN given refers to periodic acid, Na salt; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

periodate : A monovalent inorganic anion obtained by deprotonation of periodic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Periodic Acid: A strong oxidizing agent. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID167232
CHEBI ID49826
MeSH IDM0053868
PubMed CID65185
CHEMBL ID1161637
CHEBI ID29149
MeSH IDM0053868

Synonyms (48)

Synonym
periodate
tetraoxidoiodate(1-)
CHEBI:49826
15056-35-6
tetraoxoiodate(1-)
tetraoxoiodate(vii)
io4(-)
[io4](-)
metaperiodate
bdbm50159782
unii-b45a1bum4q
periodate ion
b45a1bum4q ,
periodate(1-)
iodate (io4-)
periodate (io41-)
iodate (io41-)
KHIWWQKSHDUIBK-UHFFFAOYSA-M
DTXSID80164573
Q27104724
periodic acid (hio4)
[io3(oh)]
tetraoxoiodic acid
hydrogen tetraoxoiodate
hydroxy-lambda(7)-iodanetrione
periodsaeure
CHEBI:29149 ,
13444-71-8
ueberiodsaeure
periodic acid
hio4
hydroxidotrioxidoiodine
hoio3
PEJ ,
CHEMBL1161637
A800990
d4b1481b2j ,
einecs 236-585-6
unii-d4b1481b2j
metaperiodic acid
FT-0689178
KHIWWQKSHDUIBK-UHFFFAOYSA-N
AKOS024437459
13445-51-7
periodic acid (hio4),dihydrate (8ci,9ci)
Q27887090
Q27110318
DTXSID701015530

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Metaperiodate denaturing treatment of the SRP-A glycans before injection into rats did not modify the immunogenicity of the SRP-A antigens."( Induction of a protective immune IgE response in rats by injection of defined antigens of schistosomulum-released products: immunochemical properties of the target antigens.
Auriault, C; Capron, A; Damonneville, M; Pierce, A; Strecker, G; Thorel, T; Verwaerde, C, 1986
)
0.99

Toxicity

ExcerptReferenceRelevance
"The carbohydrate in the toxic glycoprotein ricin was chemically modified by simultaneous treatment with sodium metaperiodate and sodium cyanoborohydride."( Modification of the carbohydrate in ricin with metaperiodate and cyanoborohydride mixtures: effect on binding, uptake and toxicity to parenchymal and non-parenchymal cells of rat liver.
Price, RJ; Skilleter, DN; Thorpe, PE, 1985
)
0.27
" Toxic activity was present only in the fractions containing glucose."( Cytotoxicity of the glycolipid region of streptococcal lipoteichoic acid for cultures of human heart cells.
Beachey, EH; Dale, JB; Simpson, WA, 1982
)
0.26
" A purified, toxic Quillaja triterpenoid fraction with strong adjuvant activity, designated QH-B, was used to study whether modification of the carbohydrate moiety with sodium periodate would alter the toxicity without harming adjuvant activity and cholesterol-binding capacity."( Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
Behboudi, S; Fekadu, M; Kenne, L; Morein, B; Rönnberg, B, 1997
)
0.3
" These conjugates were tested for their toxic effects on various tumor target cells as measured either by their inhibition of RNA synthesis or by their reduction of the growth of the tumor cells after transplantation."( The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies.
Arnon, R; Hurwitz, E; Levy, R; Maron, R; Sela, M, 1975
)
0.25
"The carbohydrate in the toxic glycoprotein ricin was chemically modified by simultaneous treatment with sodium metaperiodate and sodium cyanoborohydride."( Modification of the carbohydrate in ricin with metaperiodate and cyanoborohydride mixtures: effect on binding, uptake and toxicity to parenchymal and non-parenchymal cells of rat liver.
Price, RJ; Skilleter, DN; Thorpe, PE, 1985
)
0.74
" Toxic activity was present only in the fractions containing glucose."( Cytotoxicity of the glycolipid region of streptococcal lipoteichoic acid for cultures of human heart cells.
Beachey, EH; Dale, JB; Simpson, WA, 1982
)
0.26
" A purified, toxic Quillaja triterpenoid fraction with strong adjuvant activity, designated QH-B, was used to study whether modification of the carbohydrate moiety with sodium periodate would alter the toxicity without harming adjuvant activity and cholesterol-binding capacity."( Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
Behboudi, S; Fekadu, M; Kenne, L; Morein, B; Rönnberg, B, 1997
)
0.3

Pharmacokinetics

ExcerptReferenceRelevance
" After construction of a pharmacokinetic model, the Kuptake (850 nmol/l) and the number of capturing cells were determined; uptake was half the initial plasma concentration in about 10 min."( Effect of prosthetic sugar groups on the pharmacokinetics of glucose-oxidase.
Demignot, S; Domurado, D, 1987
)
0.27

Compound-Compound Interactions

ExcerptReferenceRelevance
" This study is aimed at discriminating between them, on the basis of the degree of acetylation and the acceptor sugars, by means of lectins combined with neuraminidase digestion and treatment with oxidizing and deacetylating agents."( Sialic acids in the chicken anterior lingual glands detected by lectins combined with enzymatic degradation and oxidizing agents.
Ceccarelli, P; Menghi, G; Scocco, P, 1995
)
0.29
"A series of alginates isolated from the stem and leaf of a brown algae (Laminaria hyperborea), bacterial mannuronan, in vitro epimerized mannuronans, and periodate oxidized alginates were analyzed by size-exclusion chromatography (SEC) combined with online multiangle laser light scattering (MALS) and viscometry (collectively abbreviated SMV)."( A study of the chain stiffness and extension of alginates, in vitro epimerized alginates, and periodate-oxidized alginates using size-exclusion chromatography combined with light scattering and viscosity detectors.
Christensen, BE; Kristiansen, KA; Vold, IM, 2006
)
0.33
" This study is aimed at discriminating between them, on the basis of the degree of acetylation and the acceptor sugars, by means of lectins combined with neuraminidase digestion and treatment with oxidizing and deacetylating agents."( Sialic acids in the chicken anterior lingual glands detected by lectins combined with enzymatic degradation and oxidizing agents.
Ceccarelli, P; Menghi, G; Scocco, P, 1995
)
0.29
"A series of alginates isolated from the stem and leaf of a brown algae (Laminaria hyperborea), bacterial mannuronan, in vitro epimerized mannuronans, and periodate oxidized alginates were analyzed by size-exclusion chromatography (SEC) combined with online multiangle laser light scattering (MALS) and viscometry (collectively abbreviated SMV)."( A study of the chain stiffness and extension of alginates, in vitro epimerized alginates, and periodate-oxidized alginates using size-exclusion chromatography combined with light scattering and viscosity detectors.
Christensen, BE; Kristiansen, KA; Vold, IM, 2006
)
0.33

Dosage Studied

ExcerptRelevanceReference
" An in vivo metabolism study in rats dosed with a physiological dose of 1alpha,25-dihydroxy-[26,27-3H]vitamin D3 confirmed the absence of 26-hydroxylation of the hormone."( 26-Hydroxylation of 1alpha,25-dihydroxyvitamin D3 does not occur under physiological conditions.
DeLuca, HF; Endres, B, 2001
)
0.31
" The methods were applied to the analysis of dosage forms with results comparable to those given by the official methods."( Titrimetric micro-determination of therapeutically active phenothiazines using periodate.
Basavaiah, K; Manjunatha Swamy, J, 2001
)
0.31
"L(-1) cytosolic Ca2+, a significant 'hump' or plateau at the base of the dose-response relationship to Ap5A was revealed."( Diadenosine pentaphosphate is a potent activator of cardiac ryanodine receptors revealing a novel high-affinity binding site for adenine nucleotides.
Carter, SM; Chen, Y; Sitsapesan, R; Song, L, 2009
)
0.35
" Kinetic experiments indicated that the decay of SDZ was susceptible to the dosage of nZVI and PI, but was barely affected by pH values (4."( Surface-mediated periodate activation by nano zero-valent iron for the enhanced abatement of organic contaminants.
Ji, W; Shao, Y; Wu, D; Xu, L; Zeng, Y; Zhang, H; Zong, Y, 2022
)
0.72
" The change of shrinkage temperature showed that the dosage of sodium periodate had the greatest influence on the shrinkage temperature."( Preparation and application of tremella polysaccharide based chrome free tanning agent for sheepskin processing.
Gao, D; Hu, L; Li, H; Liu, Z; Mo, H; Wang, L; Xu, D; Yao, L; Zhang, J, 2023
)
0.91
" Specifically, the inhibition effect of solar/PI on bacteria did not result in enhanced membrane permeability under appropriate PI dosage (<200 μM), which greatly reduced the risk of secondary contamination of eARGs released by traditional disinfection."( Solar/periodate inhibits ARGs transformation by degradation of DNA without damaging cell membrane.
Chen, C; Feng, M; Ye, C; Yu, X; Zhang, K, 2024
)
1.44
" The carrier-specific and nonspecific activity can be distinguished by dosage optimum, antigen requirements, binding specificity for carrier, and in the requirement for additional splenic adherent accessory cell involvement."( Generation of T-helper cells in vitro. II. Analysis of supernates derived from T-helper cell cultures.
Gordon, DS; McDougal, JS, 1977
)
0.26
" TIHA did not produce any bleeding at supramaximal antithrombotic dosage in a rat tail bleeding and a rabbit ear blood loss model and it did not augment ADP-induced aggregation of platelets."( Partially N-desulfated heparin as a non-anticoagulant heparin: some physico-chemical and biological properties.
Bertrand, H; Maillard, M; Malazzi, P; Sache, E, 1989
)
0.28
" An in vivo metabolism study in rats dosed with a physiological dose of 1alpha,25-dihydroxy-[26,27-3H]vitamin D3 confirmed the absence of 26-hydroxylation of the hormone."( 26-Hydroxylation of 1alpha,25-dihydroxyvitamin D3 does not occur under physiological conditions.
DeLuca, HF; Endres, B, 2001
)
0.31
" The methods were applied to the analysis of dosage forms with results comparable to those given by the official methods."( Titrimetric micro-determination of therapeutically active phenothiazines using periodate.
Basavaiah, K; Manjunatha Swamy, J, 2001
)
0.31
" No interference could be observed from the excipients commonly present in dosage forms."( Simple fluorimetric method for determination of certain antiviral drugs via their oxidation with cerium (IV).
Askal, HF; Darwish, IA; Khedr, AS; Mahmoud, RM,
)
0.13
"L(-1) cytosolic Ca2+, a significant 'hump' or plateau at the base of the dose-response relationship to Ap5A was revealed."( Diadenosine pentaphosphate is a potent activator of cardiac ryanodine receptors revealing a novel high-affinity binding site for adenine nucleotides.
Carter, SM; Chen, Y; Sitsapesan, R; Song, L, 2009
)
0.35
"Spectrophotometric methods are proposed for the determination of drugs containing a phenol group [salbutamol sulphate (SLB), ritodrine hydrochloride (RTD), isoxsuprine hydrochloride (IXP)] and drugs containing an aromatic amine group [dapsone hydrochloride (DAP), sulfamethoxazole (SFM), and sulfadiazine (SFD)] in pharmaceutical dosage forms."( Use of N, N-diethyl-p-phenylenediamine sulphate for the spectrophotometric determination of some phenolic and amine drugs.
Gowda, AK; Nagaraja, P; Shivakumar, A; Shrestha, AK, 2010
)
0.36
" Kinetic experiments indicated that the decay of SDZ was susceptible to the dosage of nZVI and PI, but was barely affected by pH values (4."( Surface-mediated periodate activation by nano zero-valent iron for the enhanced abatement of organic contaminants.
Ji, W; Shao, Y; Wu, D; Xu, L; Zeng, Y; Zhang, H; Zong, Y, 2022
)
0.72
"The rats in both models exhibited obvious collagen fibrosis and the severity of the lung injury increased with time after exposure to respective dosage increased."( Pathological Comparison of Rat Pulmonary Models Induced by Silica Nanoparticles and Indium-Tin Oxide Nanoparticles.
Chang, M; Guan, Y; Liu, N; Wang, Y; Yao, S; Yu, Y; Zhou, Q, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
iodine oxoanion
monovalent inorganic anionAny inorganic anion with a valency of one.
iodine oxoacid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 1Homo sapiens (human)Ki14,600.00000.00001.372610.0000AID238410
Carbonic anhydrase 2Homo sapiens (human)Ki75,800.00000.00000.72369.9200AID238440
Carbonic anhydrase 4Homo sapiens (human)Ki226,000.00000.00021.97209.9200AID238441
Carbonic anhydrase 5A, mitochondrialHomo sapiens (human)Ki15,700.00000.00001.27259.9000AID238411
Carbonic anhydrase 9Homo sapiens (human)Ki30,300.00000.00010.78749.9000AID238442
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (16)

Processvia Protein(s)Taxonomy
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
bicarbonate transportCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (23)

Processvia Protein(s)Taxonomy
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 4Homo sapiens (human)
rough endoplasmic reticulumCarbonic anhydrase 4Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentCarbonic anhydrase 4Homo sapiens (human)
Golgi apparatusCarbonic anhydrase 4Homo sapiens (human)
trans-Golgi networkCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
external side of plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cell surfaceCarbonic anhydrase 4Homo sapiens (human)
membraneCarbonic anhydrase 4Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 4Homo sapiens (human)
transport vesicle membraneCarbonic anhydrase 4Homo sapiens (human)
secretory granule membraneCarbonic anhydrase 4Homo sapiens (human)
brush border membraneCarbonic anhydrase 4Homo sapiens (human)
perinuclear region of cytoplasmCarbonic anhydrase 4Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
mitochondrial matrixCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
cytoplasmCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID238441Inhibitory activity against human Carbonic anhydrase IV2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
AID238442Inhibitory activity against human Carbonic anhydrase IX2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
AID238411Inhibitory activity against human Carbonic anhydrase V2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
AID238440Inhibitory activity against human Carbonic anhydrase II2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
AID238410Inhibitory activity against human Carbonic anhydrase I2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (3,665)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902662 (72.63)18.7374
1990's376 (10.26)18.2507
2000's284 (7.75)29.6817
2010's241 (6.58)24.3611
2020's102 (2.78)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.81 (24.57)
Research Supply Index8.25 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index73.12 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.09%)5.53%
Trials1 (0.03%)5.53%
Reviews8 (0.76%)6.00%
Reviews48 (1.26%)6.00%
Case Studies2 (0.19%)4.05%
Case Studies22 (0.58%)4.05%
Observational0 (0.00%)0.25%
Observational1 (0.03%)0.25%
Other1,042 (98.96%)84.16%
Other3,738 (98.11%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]